Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Kangzhe Biotech
Shenzhen, Guangdong, China
- Ownership
- Private
- Employees
- ~6
- Development stage
- Other
01
Overview
Shenzhen Kangzhe Pharmaceutical is a commercial stage subsidiary of China Medical System Holdings, with multiple approved and late-stage pipeline products; notable assets include namodenoson (Phase 3, hepatocellular carcinoma) and a portfolio of small molecules, peptide drugs, and bispecific antibodies. The group has demonstrated long-term survival benefit in liver cancer, and drives R&D through proprietary antibody platforms. Approved assets include diazepam (for seizures), methotrexate (for rheumatoid arthritis), and others.
- Therapeutic areas
- OncologyNeurologyImmunologyCardiovascular
- Modalities
- Small moleculeSynthetic peptideMonoclonal antibodyBispecific antibodyProtein therapeuticsImmunoglobulinHerbal medicine
- Industry
- Biotech
02
Partnerships
China Medical System HoldingsCan-Fite BioPharmaAlpha CognitionAtom Therapeutics
Beyond the preview
Go deeper on Shenzhen Kangzhe Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen Kangzhe Biotech.